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Abstract
Background: Advance care planning (ACP) is a continuous, dynamic process of reflection and dialogue between
an individual, those close to them and their healthcare professionals, concerning the individual’s preferences and
values concerning future treatment and care, including end-of-life care. Despite universal recognition of the
importance of ACP for people with dementia, who gradually lose their ability to make informed decisions
themselves, ACP still only happens infrequently, and evidence-based recommendations on when and how to
perform this complex process are lacking. We aimed to develop evidence-based clinical recommendations to guide
professionals across settings in the practical application of ACP in dementia care.
Methods: Following the Belgian Centre for Evidence-Based Medicine’s procedures, we 1) performed an extensive
literature search to identify international guidelines, articles reporting heterogeneous study designs and grey
literature, 2) developed recommendations based on the available evidence and expert opinion of the author group,
and 3) performed a validation process using written feedback from experts, a survey for end users (healthcare
professionals across settings), and two peer-review groups (with geriatricians and general practitioners).
Results: Based on 67 publications and validation from ten experts, 51 end users and two peer-review groups (24
participants) we developed 32 recommendations covering eight domains: initiation of ACP, evaluation of mental
capacity, holding ACP conversations, the role and importance of those close to the person with dementia, ACP
with people who find it difficult or impossible to communicate verbally, documentation of wishes and preferences,
including information transfer, end-of-life decision-making, and preconditions for optimal implementation of ACP.
Almost all recommendations received a grading representing low to very low-quality evidence.
Conclusion: No high-quality guidelines are available for ACP in dementia care. By combining evidence with expert
and user opinions, we have defined a unique set of recommendations for ACP in people living with dementia.
These recommendations form a valuable tool for educating healthcare professionals on how to perform ACP across
settings.
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Background
Due to the aging population, the number of people with
dementia is increasing. In 2015, the World Health
Organization (WHO) estimated the number of people
living with dementia at 35.6 million. This is expected to
double by 2030 and even triple by 2050 [1].
To enable caregivers to improve the quality of life of
people with dementia, they need to know what is im-
portant to them, what specific concerns they are facing
and how and where they want to receive care. However,
people living with dementia gradually lose their ability to
make informed decisions themselves [2]. Therefore it
may be necessary to have these discussions in the earlier
stages of dementia, when the person is still able to make
decisions and express their values and preferences [3].
Providing high-quality care for people with dementia
requires advance care planning (ACP) [4]. ACP is a con-
tinuous, dynamic process of early reflection and dialogue
between a person with dementia, those close to them
and the relevant healthcare professionals concerning the
person’s preferences and values when it comes to future
treatment and care, including end-of-life care [5]. If they
wish, the contents of these conversations can be re-
corded in the form of an advance directive, and a proxy
decision-maker can be appointed or a permanent power
of attorney can be granted in anticipation of future de-
terioration [6, 7].
Despite the widespread recognition of the importance
of ACP for people living with dementia [1–3, 8–10], the
reality is different, and only a minority of people with
dementia get the opportunity to engage in ACP [11]. For
example, studies show that a minority of deceased nurs-
ing home residents with dementia had an advance dir-
ective [12–14] and that general practitioners (GPs) had
communicated infrequently about future end-of-life care
options. For example, only 22% of deceased nursing
home residents in Belgium had an ACP conversation
[13]. Even among a representative sample of non-sudden
deaths in Belgium and the Netherlands, only 34% of pa-
tients had engaged in ACP with their GP [15]. People
with dementia are often a disadvantaged group when it
comes to being invited for ACP conversations at an ap-
propriate time and cognitive decline is often seen as a
barrier to initiate ACP [16–26].
Although several organisations and professionals have
called for guidance on when and how to perform ACP
in this specific population [1–3], guidelines that have
been developed in a systematic way using the best evi-
dence available are lacking. In an attempt to improve the
prevalence, quality and consistency of ACP in people
with dementia, we aimed to develop clinical recommen-
dations for applying and conducting ACP in practice, to
provide support for healthcare staff (physicians, includ-
ing GPs, nurses, allied health and care workers) who
work with people living with dementia in the commu-
nity, residential and hospital settings.
Methods
No informed consent was needed for this study. The pro-
cedure developed by the Belgian Centre for Evidence-
Based Medicine (CEBAM) (in close cooperation with the
Belgian Federal Public Service Health, Food Chain Safety
and Environment and the two professional Belgian GP or-
ganisations Domus Medica and Société Scientifique de
Médecin General or SSMG) was used as methodology to
develop a guideline. The procedure entails: 1) a literature
search to identify what is already known about ACP in
people living with dementia, 2) the development of rec-
ommendations based on the existing evidence and expert
opinion of the author group, and 3) a validation process to
provide feedback on the clarity, acceptability and import-
ance and to discuss possible barriers to implement the
recommendations.
1) Literature search
Search framework: selection of research questions and
clinical themes on ACP and clinical practice
A multidisciplinary group of authors was assembled to
develop the recommendations: a research coordinator, a
geriatrician, two GPs, an expert in dementia care, a
nurse, two psychologists and the director of the Flanders
Federation for Palliative Care. Collectively, they have ex-
tensive experience in palliative, primary and dementia
care in different settings in Flanders (Belgium). Based on
their own experience and obstacles they have encoun-
tered in practice, this author group formulated clinical
research questions related to ACP in people with de-
mentia. Obstacles are defined as those areas in the ACP
process that cause ACP not to be initiated at the appro-
priate time or not to be performed at all. The clarity, ap-
plicability and completeness of each clinical research
question was evaluated in semi-structured interviews by
SM and DN with 28 GPs, of whom 14 also act as coord-
inating advisory physicians or CAPs in a nursing home
and of whom 14 are heads of residential care, all from
different nursing homes in Flanders and all familiar with
the concept and practice of ACP. Through discussion
and consensus within the team of authors, these were
categorized to six main clinical themes to guide the lit-
erature search (see Table 1).
Search for evidence
We undertook a stepwise approach to search the scien-
tific literature for evidence about ACP in people with de-
mentia related to the six selected clinical themes.
Publications were included if (i) they were published in
Dutch, French, English or German, (ii) their main theme
was ACP in people with dementia, or, if a guideline,
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ACP was included in the goals, or was one of the out-
come recommendations. Publications were excluded if
ACP in people with dementia was not the focus of the
article. Meta-analyses and systematic reviews were ex-
cluded if they were published before 2004, to avoid in-
cluding publications that approach ACP too narrowly.
The authors believe that the majority of publications
only started defining ACP from 2004 onward as a more
comprehensive process that is not limited to advance di-
rectives [27].
The search consisted of three steps to identify relevant
1) international guidelines, 2) systematic reviews and
meta-analysis and 3) primary studies (randomised con-
trolled trials and observational research). Search terms
and a PRISMA flowchart are provided in Fig. 1. The
quality assessment procedure is described below.
1) We searched for existing guidelines concerning
ACP and dementia in guideline databases G-I-N
(Guidelines International Network), NHS (National
Health Service), NGC (National Guideline Clearing-
house), and a databank of the NZGG (New Zealand
Guideline Group), making use of two EBM-search
engines (TRIP and SUMSEARCH).
2) Systematic reviews and meta-analyses were
searched for by two authors (SM and DN) using
five major bibliographic databases (Cochrane
Database of Systematic Reviews, Medline, Embase,
CINAHL and PsycINFO).
3) Two authors independently performed a focused
literature search in Medline and Embase for
primary studies (randomised controlled trials or
observational studies) to answer clinical questions
which could not be answered through guidelines,
systematic reviews and/or meta-analysis. In
addition, by using the snowballing method and
based on expert advice, additional articles that may
have been missed were added if perceived relevant
by the authors.
Quality assessment
The quality of the guidelines and systematic reviews
and/or meta-analyses was independently checked by
pairs of authors against the Appraisal of Guidelines Re-
search and Evaluation (AGREE II) instrument [28] for
guidelines and a checklist to assess the methodological
quality of systematic reviews [29], as recommended by
CEBAM and Cochrane Netherlands [30–35]. The
AGREE II instrument is an international 23-item tool to
assess the quality and reporting of practice guidelines
that is organised into six domains. All items are rated on
a 7-point scale (1 ‘strongly disagree’ – 7 ‘strongly agree’).
The checklist used for assessment of systematic reviews
was developed by Cochrane Netherlands (http://
netherlands.cochrane.org; only available in Dutch). It has
been shortened by the authors. It now consists of 12 ‘yes
– no – cannot answer/too little information in the
paper’ questions, organised into three categories: valid-
ity, importance and applicability. Questions for assess-
ment include: 1) Was the search request adequately
formulated? 2) Was the search performed adequately? 3)
Was the selection procedure for the articles performed
adequately? 4) Was the quality assessment performed
adequately? 5) Is the description of how the data extrac-
tion was organised adequate? 6) Were the most import-
ant characteristics of the included research reported? 7)
Was the meta-analysis carried out appropriately? 8) Is
there statistical pooling? 9) Is the research valid? 10) Are
the results adequately described? 11) Are the findings
applicable in the region? 12) Is this applicable in daily
practice? (translation by authors). The quality score is
Table 1 The six clinical themes and examples of research
questions used to search for evidence
Theme 1 Mental capacity
E.g.: How can mental capacity be defined in the context
of healthcare for people living with dementia?
How can mental capacity be evaluated?
Theme 2 Advance care planning in people living with dementia
E.g.: What are the specific points of interest in the involvement
of people living with dementia in advance
care planning? For early stages: How do we deal with
persons who lack disease insight? What if people
are resistant to talk about future care? For mild stages
of dementia in whom verbal communication is
still possible? For people with dementia in whom verbal
communication about ACP is too difficult or
not possible
What if the wishes of the mentally competent person
(the ‘then self’) does not correspond to the
actual wishes of the person now lacking in mental
capacity (the ‘now self’) or to the ‘best interests’
of the person?
Theme 3 Family and environment of people living with dementia
E.g.: What is the role of family and the immediate social
circle in advance care planning throughout the
different stages of dementia?
How can healthcare professionals support families and
those in the person’s immediate environment
in taking on these roles?
Theme 4 Specifics for advance care planning in people living
with early onset dementia
E.g.: Are there specific points of interest concerning people
living with early onset dementia and advance
care planning?
Theme 5 Documentation and registration of ACP
E.g.: What aspects of ACP need to be registered? How do
we transfer information to different settings?
Theme 6 Organizational issues
E.g.: What is the role in the ACP process of different
professionals? What are the optimal preconditions
for ACP in different settings?
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the number of times ‘yes’ was applied to the questions (1
‘low quality’ - 12 ‘high quality’). As specified by the
CEBAM procedure, we would have followed the scien-
tific process of the ADAPTE procedure when the
AGREE assessment was performed, to adapt useful
guidelines to the local context through a process that
can be found elsewhere [31–35]. However, none of the
guidelines met these criteria and because of the limited
number of systematic reviews on ACP and dementia the
authors decided to include other primary studies (rando-
mised controlled trials and observational research), opin-
ion pieces and grey literature as well. An overview of all
included publications is provided in Table 2.
2) Development of recommendations
Data extraction followed a structured process in which
the research questions were divided by theme and given
to a pair of authors for each of the six clinical themes.
Each pair reviewed a selection of the included literature
and extracted data (‘key messages’) that was applicable
to their clinical research question. Extracted data was
stored and structured in a Microsoft Excel™ matrix.
These data were then used to inform the development
of a first draft of possible recommendations drawn up by
two authors (GA and LVdB). Two authors (GA and JS)
additionally assessed the strength of each recommenda-
tion through critical appraisal of the evidence, against
Fig. 1 PRISMA flow diagram of the study screening, eligibility, selection and inclusion process ACP advance care planning; G-I-N Guidelines International
Network; NHS National Health Service; NGC National Guideline Clearinghouse; NZGG New Zealand Guidelines Group; TRIP Trip medical database; MeSH
Medical Subject Headings; AGREE Appraisal of Guidelines for Research and Evaluation
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Table 2 Overview and characteristics of publications included (n = 67)
Systematic reviews and meta-analysis (n = 9)
First author (year of publication) Study type Number of publications included (n) Quality score ranging from
1 to 12* (number of items
that could not be answered
due to too little information
in the paper)
1 Dening (2011) Review 17 8 (4)
2 Robinson (2012) Systematic review 4 7 (5)
3 Seeber (2012) Review 43 6 (5)
4 Van der Steen (2010) Systematic review 45 4 (8)
5 Sampson (2010) Review (editorial) 2 (2)
6 Goodman (2010) Integrative review 68 8 (3)
7 De Boer (2010) Literature review Information not available 3 (7)
8 Raymond (2014) Critical synthesis 8 6 (3)
9 Van der Steen (2014) Systematic review 33 7 (4)
Other (n = 58)
First author (year of publication) Methods Setting (sample, n)
Quantitative and experimental research
1 Detering (2010) Randomised controlled trial Medical inpatients aged
80 or more (n = 309)
2 Vandervoort (2012) Cross-sectional retrospective
survey
Deceased residents with
dementia in 345 nursing
homes (n = 764)
3 De Gendt (2010) Cross-sectional retrospective
survey
Nursing home
administrators (n = 345)
4 Benkendorf (1997) Prospective cohort study Patients > or = 19 years
old with arrest of presumed
cardiac cause, with locations
at home or at a nursing
home (n = 2348)
5 De Gendt (2013) Cross-sectional retrospective
survey
Deceased nursing home
residents (n = 1240)
6 Sampson (2011) Exploratory randomised
controlled trial
Family caregivers of patients
with severe dementia
(n = 33; IG: n = 22; CG: n = 11)
7 Brazil (2015) Cross-sectional survey General practitioners (n = 133)
8 Grisso (1997) Quasi-experimental trial Acutely ill inpatients with a
diagnosis of schizophrenia
or schizoaffective disorder
(IG: n = 40)
9 Givens (2009) Prospective cohort study Nursing home residents with
advanced dementia and their
healthcare proxies (n = 223)
10 Vandervoort (2013) Cross-sectional retrospective
survey
Deceased residents with
dementia in 69 nursing
homes (n = 198)
11 Baile (2002) Questionnaires Oncologists (n = 167)
12 Szafara (2012) Prospective cohort study Residents (n = 1044 US,
n = 513 Netherlands)
13 van der Steen (2012) Prospective cohort study Residents with advanced
dementia (n = 94)
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Table 2 Overview and characteristics of publications included (n = 67) (Continued)
Qualitative research
14 Garand (2011) Semi-structured interviews Persons (n = 127) with a
diagnosis of MCI or early
AD (n = 72) or moderate
to severe AD (n = 55)
15 de Boer (2012) Semi-structured interviews Individuals diagnosed with
early-stage AD (n = 24)
16 Poppe (2013) In-depth interviews Patients with memory
problems or mild dementia
(n = 2) and eight carers
(n = 8) and staff members
from a memory clinic and
a community mental health
team (n = 11)
17 Chan (2011) Semi-structured interviews Nursing home residents
(n = 42)
18 Piers (2013) Semi-structured interviews Elderly patients with limited
prognosis (n = 38)
19 Ashton (2014) Interviews Family caregivers within a
specialist dementia unit
(n = 12)
20 Levi (2010) Focus groups Older individuals (n = 23)
21 Kim Suh (2011) Interviews Persons with AD (n = 188)
22 Shanley (2009) Interviews Managers from residential
aged care facilities (n = 41)
23 Dening (2012) Nominal group study People with dementia (n = 6),
carers (n = 5) and dyads of
people with dementia and
carers (n = 6) attending
memory assessment services
24 Dening (2012) Whole-systems qualitative
study based on interviews
and focus groups
Nine carers of people with
dementia (n = 9) and focus
groups (n = 6) with health
care professionals with mixed
professions (n = 26) and
individual interviews with
health care professionals
with mixed professions (n = 15)
25 Hirschman (2006) Semi-structured interviews Family members of patients
with advanced dementia
(n = 30)
26 Hirschman (2008) Semi-structured interviews Family members of patients
with advanced dementia (n = 30)
27 Dickinson (2013) Semi-structured interviews People with mild to moderate
dementia (n = 17) and family
carers (n = 29)
28 Hoe (2007) Semi-structured interviews Care recipient and caregiver
dyads (n = 191)
29 Steeman (2007) Interview study Elderly people with probable mild
dementia and their family
members (n = 20)
30 Zimmerman (2015) Interview study Family members of decedents
from 118 nursing home and
residential settings (n = 264)
31 McMahan (2013) Semi-structured focus groups Focus groups with participants
from a Veterans Affairs and county
hospital and the community (n = 13)
32 Steeman (2013) Longitudinal interview study Elderly persons with early-stage
dementia (n = 17)
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Table 2 Overview and characteristics of publications included (n = 67) (Continued)
Mixed methods research
33 Silvester (2012) Survey (1) and review
of existing ACP-related
documentation (2)
(1) staff of aged care facilities
(n = 45); (2) aged care facilities
(n = 12)
34 Froggatt (2009) Survey (1) and semi-
structured interviews (2)
(1) care home managers
(n = 213); (2) care home
managers (n = 15)
35 de Boer (2011) Survey (1) and semi-
structured interviews (2)
(1) elderly care physicians
(n = 434); (2) physicians
(n = 11) and relatives (n = 8)
36 Van der steen (2014) Five-round Delphi study experts from 23 countries (n = 64)
Guidelines, reports, theses
37 Van Mechelen (2014) Guideline NA
38 Clayton (2007) Guideline NA
39 WHO (2012) Report NA
40 Harle (2008) Report NA
41 Titler (2008) Guideline NA
42 Vellinga (2006) Thesis NA
43 Church (2007) Guideline NA
44 Conroy (2009) Guideline NA
45 American Medical Association (1999) Guideline NA
Opinion and reflection papers
46 Harvey (2006) NA NA
47 Lemmens (2012) NA NA
48 Gillick (2012) NA NA
49 Scott (2012) NA NA
50 Berghmans (2001) NA NA
51 Burlà (2014) NA NA
52 Kim Suh (2006) NA NA
53 Gillick (2004) NA NA
54 Juthani-Mehta (2015) NA NA
55 Mold (1991) NA NA
56 Smith (2013) hypothetical case
report (n = 2)
2
Grey literature
57 Van der steen (2011) Leaflet (Dutch) NA
58 Keirse (2009) Leaflet (Dutch) NA
NA Not Applicable, GP General Practitioner, IG Intervention Group, CG Control Group, AD Alzheimer’s Disease
*Using the checklist that was developed by Cochrane Netherlands (http://netherlands.cochrane.org; only available in Dutch). It has been slightly adapted by the
authors. It consists of 12 ‘yes – no - cannot answer/too little information in the paper’ questions, organised into three domains (validity, importance and
applicability): 1) Was the search request adequately formulated? 2) Was the search performed adequately? 3) Was the selection procedure for the articles
performed adequately? 4) Was the quality assessment performed adequately? 5) Is the description of how the data extraction was organised adequate? 6) Were
the most important characteristics of the included research reported? 7) Was the meta-analysis carried out appropriately? 8) Was there statistical pooling? 9) Is the
research valid? 10) Are the results adequately described? 11) Are the findings applicable in the region? 12) Is this applicable in daily practice? (translation by au-
thors). The quality score is the number of times ‘yes’ was applied to the questions (1 ‘low quality’ - 12 ‘high quality’)
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the criteria of the Grading of Recommendations Assess-
ment, Development and Evaluation (GRADE) working
group [30–35]. The quality of the included literature and
each recommendation can be found in Table 2 and
Table 3.
When there was not enough evidence on a clinical re-
search question, the author group formulated an expert
opinion. Each step in the decision process was discussed
and approved within the author group. The recommen-
dations were finally re-organized into eight domains.
3) Validation process
Because high-quality evidence was lacking for many of
the clinical research questions, we conducted additional
validation of the recommendations. The results of this
validation round were discussed within the author group
and recommendations were revised if necessary and
applicable.
1) To assess the clarity, acceptability and importance
of each formulated recommendation, an online
survey was set up. This survey was then e-mailed or
sent with the newsletter of the Flemish Expertise
Centre on Dementia Care and the Flemish Council
for the Elderly to potential end users (healthcare
professionals working with people living with
dementia) across settings (primary care, home
care, residential care and hospitals) in Flanders. The
respondents were asked to score each recommenda-
tion on a scale of 1 to 7 for (i) clarity, (ii) acceptability
and (iii) importance. As a result of this validation
survey the authors provided more information for
some of the terms used in the recommendation. For
example: ‘care goals’ were defined more clearly by
providing several examples such as “prolonging life,
preserving function or control, optimal comfort,
improving quality of life, a ‘good death’ or support
from those close to them”.
2) To evaluate possible barriers to the implementation
of each recommendation, we organised two
meetings of established peer review groups of GPs
and geriatricians on March 8 and April 28, 2016 to
provide feedback. Nearly 97% of all physicians in
Belgium are affiliated with peer review groups like
these and are obliged to attend two out of four
meetings per year for accreditation [36].
3) Finally, we provided several experts (other than the
authors) with the first draft of the
recommendations (informed by 1 and 2) for them
to formulate comments to improve them. Experts
are healthcare professionals specifically selected by
the authors from different disciplines, all with an
extensive knowledge of the daily practice of
dementia care and ACP.
Results
Selection of research questions and clinical themes
The research questions and clinical themes that needed
to be addressed according to the multidisciplinary
author group are provided in Table 1.
Search for evidence and expert and user validation
Figure 1 summarises the flow of selected publications
through the review of all literature. A total of 67 publica-
tions constituted the evidence and validation base upon
which the recommendations were developed (Table 2).
In total, 51 end users, 10 experts, 12 GPs and 12 geria-
tricians confirmed the importance, relevance and clarity
of the recommendations and helped to further define
them. Characteristics of the participants in the validation
process are described in Table 4.
Recommendations
We formulated 32 recommendations covering eight do-
mains: 1) initiation of ACP, 2) evaluation of mental cap-
acity, 3) holding ACP conversations, 4) the role and
importance of those close to the person with dementia,
5) ACP when it is difficult or no longer possible to com-
municate verbally, 6) documentation of wishes and pref-
erences, including information transfer, 7) end-of-life
decision-making and 8) preconditions for optimal imple-
mentation. The main recommendations within each of
the eight main domains are stated in bold and described
below. The recommendations are presented in Table 3,
with accompanying scores indicating their strength and
supporting references.
Initiation of ACP
Start ACP as early as possible and integrate ACP into
the daily care of people living with dementia, ideally
before diagnosis or any cognitive decline [9, 25, 37–42].
Preferably, ACP should be performed on several occa-
sions. These conversations can vary from short to
lengthy discussions depending on how the person with
dementia feels and how much time there is. They can be
planned or occur spontaneously when the opportunity
arises [23, 37–41, 43]. There are several key triggers for
ACP conversations identified in the literature: admission
to a nursing home, initiation of palliative care, deteri-
oration of the condition or upon request. Specifically
for dementia, key moments might be the period
around diagnosis [38, 44], while discussing the
overall general care plan and/or when changes
occur in health status, place of residence or finan-
cial situation [45]. Be alert for triggers and oppor-
tunities to start ACP and make use of any
opportunity to talk about ACP [46, 47]. Given the
fluctuating cognitive capacities of people with
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Table 3 Recommendations
Recommendationsa Quality of the recommendation,
according to GRADEb
Domain 1 Initiation of ACP
1 Start ACP as early as possible and integrate ACP into the daily care of people living
with dementia [10, 37, 106] [11, 38–43] Specific key moments might be:
- the period around the diagnosis of dementia [39, 44] - when discussing the
general care plan
- when changes occur in the health status, place of residence or financial situation [45]
1C
2 Be alert for triggers and opportunities to start ACP and make use of any opportunity
to talk about ACP [46, 47]
1C
3 The healthcare professional should initiate ACP conversations if the person living with
dementia and/or those close to them do not do this themselves [37, 44–47] [38, 45–48]
1C
4 Consider the person as an individual and consider their specific situation when starting
ACP conversations [43, 49]
1C
Domain 2 Evaluation of mental capacity
5 Always assume maximal mental capacity [50, 51] 1C
6 Consider mental capacity as a fluctuating rather than static condition [52], and stay
alert for signs of loss of capacity
1C
7 Judge mental capacity task-specifically i.e. for a certain decision at a particular
moment in time [11, 50, 51]
1C
8 Always stay in contact with the person him/herself and ensure their maximum
participation [1]
1C
9 Assess mental capacity through formal clinical assessment:
- where there is doubt or disagreement between healthcare professionals
and/or family
- when the decisions can have far-reaching consequences
- preferably by a multidisciplinary or interdisciplinary team with experience in
dementia
NA*
Domain 3 Performing ACP conversations
10 Adjust conversation style and content to the person’s level and rhythm [59] 1C
11 Explore who the significant people in their life are and who can be involved in
the ACP conversations, and explore who can become their legal representative [47, 52, 61]
1C
12 Lead the conversation but do not force it to become too formulaic or phased [59] 1C
13 Explore the person’s disease awareness and their expectations, ideas and possible
misconceptions concerning the disease trajectory [5]
1C
14 Where someone lacks disease awareness or is reluctant to talk about ACP, do not
insist [106, 63]
1C
15 ACP conversations can best be held on several occasions and over a longer period
of time [38, 106, 45] and cover several different topics such as the broader values of
the person, their experience of the present and their fears about the future and the
end of life, their future care goals, specific advance decisions about the end of life,
advance directives
1C
16 Try to understand the whole person living with dementia; explore their life story,
important values, norms, beliefs and preferences [17, 26]
1C
17 Explore the person’s current experiences; ask what is the perception of the person
living with dementia of their quality of life? What are their fears and concerns?
[25, 106, 52, 65]
1C
18 Explore the person’s fears and concerns for the future and for the end of life [106] 1C
19 If possible and desirable, guide the person in formulating their care goals [49, 66] 1C
20 If possible and desirable, guide the persons with formulating specific wishes
concerning specific end-of-life decisions [45]
1C
21 Explore whether the person would like to have a written advance directive or if they
have made one in the past [45]
1C
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dementia it is important to make use of spontaneous
opportunities.
Because research has shown that ACP conversations
are not often initiated by the person living with de-
mentia him/herself, healthcare professionals should
initiate them unless the person and/or those close to
them do this [37, 45–47]. Although GPs play an im-
portant role, all healthcare professionals can be in-
volved in discussing elements of ACP [46, 47]
according to their own skills [37, 45–47]. It is import-
ant to have a trusting relationship with the person
and those close to them, to have some knowledge of
the disease trajectory [37, 48] and to communicate
with the GP.
Each individual patient and situation is different.
Hence, when starting ACP conversations, one needs to
consider the person as an individual and consider
their specific situation [43, 49].
Evaluation of mental capacity
When performing ACP with people living with demen-
tia, their mental capacity should be considered. However,
a diagnosis of dementia should not automatically be
equated with loss of mental capacity. Healthcare profes-
sionals should consider the following principles:
Always assume full mental capacity [50, 51] and re-
gard it as a fluctuating, not static, condition situated
on a continuum [52]. Stay alert for signals of loss of
Table 3 Recommendations (Continued)
Recommendationsa Quality of the recommendation,
according to GRADEb
Domain 4 The role and importance of those close to them
22 Involve family or significant others as early as possible in the ACP process and
inform them about the role of a surrogate decision-maker [11, 26, 41]
1C
23 Evaluate their disease awareness and inform them about the expected disease
trajectory and possible end-of-life decisions [17, 25, 43, 82, 83]
1C
24 Pay attention to their perceptions during the ACP process [11, 26, 52, 65, 85] 1B
Domain 5 ACP when it is difficult or no longer possible to communicate verbally
25 Keep connected with the person living with dementia and ensure their
maximum participation [1]: respond to their emotions, attend to non-verbal
communication and observe their behaviour to know more about their current
quality of life, fears and desires
1C
26 Actively involve family and others close to them in the ACP process and the
expression of care goals and wishes concerning end-of-life decisions [11, 26, 82]
1C
Domain 6 Documentation of wishes and preferences, including information transfer
27 Write down in the medical/care files of the person with dementia the outcomes
of the ACP process, their values, preferences and care goals, and if applicable,
the advance directive and legal representative [26, 87, 88]
1B
28 Regularly re-evaluate as part of the ACP process; decisions can be revised at all
times [17, 26, 47]
1C
29 Communicate the outcomes of the ACP process within the care team, i.e. values,
preferences and care goals, and if applicable advance directives or legal
representatives, especially in the case of transfer to another care setting.
NA*
Domain 7 End-of-life decision-making
30 Carefully weigh the wishes (expressed and/or written down earlier) against the
current best interest of the person living with dementia, in consultation with
those close to them and the healthcare professionals involved [83, 89, 90]
1C
Domain 8 Preconditions for optimal implementation of ACP
31 Provide enough training opportunities for healthcare professionals to learn
how to conduct ACP conversations. Adequate support is essential in making
healthcare professionals confident about engaging in ACP [11, 17, 26, 94, 114]
1C
32 Integrate ACP into the mission and policy of the organization and embed it in
the organizational culture [62, 91, 95–97] [61, 96–98] [62, 96–98]
1C
NA Not applicable, ACP Advance care planning
aRecommendations without references were added only by the experts and end users during the consensus procedure
bGrading scores go from 1A to 2B, 1A representing a strong recommendation, based on a high level of evidence and 2C representing a weak recommendation
and low to very low level of evidence. A grading score of 1C represents ‘strong recommendation but low to very low level of evidence’ meaning that this
recommendation can be applied to patients and to care but may still change once higher-quality evidence is available. A grading score of 1B represents ‘strong
recommendation and moderate level of evidence’ meaning that this recommendation has enough support for it to be applied in practice. More information on
GRADE scores can be found on the website of the GRADE working group
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mental capacity. Judge mental capacity task-
specifically as the capacity for making a certain decision
at a particular moment [9, 50, 51]. Always stay in con-
tact with the person him−/herself to ensure maximal
participation [1]. A formal clinical assessment (in-
cluding substantive clinical and neuropsychological
examinations [53]) is only necessary in case of doubt
or disagreement between healthcare professionals
and/or those close to the person, or when decisions
can have far-reaching consequences, and should then
preferably be performed by a multidisciplinary team
with expertise in dementia. To be able to hold ACP
conversations with people with dementia, a general clin-
ical judgment of mental capacity as part of the conversa-
tion usually suffices. Available tools for making general
clinical judgments of mental capacity are the MacArthur
Competence Assessment Tool [54], the Vignette method
[55] or the flow chart guide from Church et al. [56].
ACP conversations
In people with dementia, cognitive activity and abstract
thinking – abilities which are needed to think about the
future – can become difficult, even in mild cases [42].
Moreover, people with dementia are likely to live in the
present and thinking about the future may cause fear or
anxiety. This does not preclude ACP but does make
ACP conversations more difficult [21, 57, 58]. To facili-
tate ACP conversations with people with dementia, the
following recommendations apply:
When engaging in a conversation with a person who
has mild/moderate dementia, adjust the communica-
tion style and content to their own level and
rhythm [59], taking into account the principles of
person-centred care [60].
Find out who are the significant people in their life,
people who may be able to be involved in the ACP
conversations, and who may be able to become their
surrogate decision-makers (if not yet appointed), while
explaining that these are people who can legally be
appointed to act on behalf of a patient when s/he is no
longer capable [47, 52, 61].
Lead the conversation but do not make it too
phased, despite the fact that ACP is often described in
such a way [59]. Because of a lack of disease awareness,
decreasing decision-making ability and imaginative cap-
acity and decreasing ability to process new information,
it will often not be possible to follow a prescribed struc-
ture [25, 43, 62]. Supporting materials, if necessary and
available, can be helpful (e.g. applications, books, etc.).
Explore the person’s disease awareness and his/her
expectations, ideas and possible misconceptions con-
cerning the disease trajectory [5]. It is important to
provide a balanced view of what living with dementia
may entail.
If someone lacks disease awareness or is reluctant
to talk about ACP, do not insist [42, 63]. It is import-
ant for people to decide their own information prefer-
ences. However, even if disease awareness is lacking, it
remains important to explore someone’s general values
and concerns as part of the ACP process [9, 64].
ACP conversations are best held on several occa-
sions over a period of time [37, 42, 45]. They can
cover several different topics: the person’s more gen-
eral values, their experience of the present and fears
about the future and the end of life, their future care
goals, their specific advance decisions about the end
of life and advance directives.
Learn to know who the person living with dementia
is ‘as a whole person’: explore their life story and most
important values, norms, ideas and preferences in order
to understand who the person is, what the significant
events in their life have been and what gives their life
meaning [15, 25, 37, 45].
Explore people’s current experiences in terms of
quality of life, fears and concerns. ACP is not only about
exploring the future, but includes a focus on the past
and the present [4, 22, 63, 65]. Explore the person’s
fears and concerns for the future and for the end of
life [42, 63].
If possible and desirable, guide the person in for-
mulating his/her care goals [8, 49, 66, 67] i.e. prolong-
ing life, preserving function or control, optimal comfort,
improving quality of life, a ‘good death’ or support from
Table 4 Professional background of the participants involved
during the validation process
Professional background N
Survey participants (end users) 51
Nurse 17
Dementia reference person 8
Social worker 5
Occupational therapist 4
Physician 3
Other healthcare professionals in various settings 14
Experts 10
Geriatric psychiatrist 1
Neurologist 1
Social worker 2
Nurse 2
General practitioner 1
Occupational therapist 1
Psychologist 2
Peer-review groups 2
Family physicians 12
Geriatrician 12
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those close to them [67, 68]. Be aware that such care
goals can change throughout the disease trajectory [58,
69, 70].
If possible and desirable, guide the person in for-
mulating specific wishes concerning specific end-of-
life decisions [45]. Most people with dementia do not
die suddenly. Often medical decisions with regard to the
provision of antibiotics, hospital admission in case of ur-
gent health problems, resuscitation and artificial fluids
are relevant [2, 71, 72]. Provide the necessary informa-
tion about different possible end-of-life decisions in de-
mentia (e.g. non-treatment decisions), and prevent
misconceptions with regard to the use of resuscitation
[73–76], artificial food and fluids [77] and antibiotics
near the end of life [78–80].
Explore whether the person would like to complete
an advance directive or whether s/he has done so in
the past [45]. It is important to stipulate that document-
ing wishes formally can be relevant for people living with
dementia, especially those who don’t have any close fam-
ily or those who value being in control. However, profes-
sionals should be aware that in some situations, advance
directives might not be specific enough to fully inform
the decision-making process. Documented wishes will
help guide end-of-life decision-making for physicians,
other care professionals and those close to the person,
and they will be most helpful if they are the result of a
continuous and in-depth communication process.
These recommendations are mainly applicable to
people who have mild or moderate dementia, with
whom verbal communication is still possible. Part 5 fo-
cuses more on people with dementia who find it difficult
or impossible to communicate verbally.
The role and importance of those close to the person with
dementia
Because of the gradual loss of mental capacity in people
living with dementia - more than in other diseases - they
are often dependent on other people [81]. Family or sig-
nificant others should preferably be involved as early
as possible in the ACP process and be informed
about the role of a surrogate decision-maker [9, 25,
40]. As part of the ACP process, it will be important to
determine who can be involved in ACP conversations,
but it can be difficult to determine when to involve them
and how many people to involve. If a legal representative
is appointed, they should be involved in ACP conversa-
tions [82]. If there is no legal representative, it will be
useful to consider who will be the first point of contact
for professionals, and how information is transferred
among other family members. Every family is unique, so
the involvement of family and those close to the person
with dementia should be evaluated on a case-by-case
basis, along with the person with dementia themselves.
Evaluate the disease awareness of those close to the
person and inform them of the expected disease trajec-
tory and possible end-of-life decisions [15, 23, 43, 83,
84]. The information preferences of those close to the per-
son with dementia should also be explored. Make sure the
information about the disease trajectory is correct
and make sure it is balanced and qualified. In many
cases the person with dementia does not experience
his/her disease as something ‘negative’ in the way that
the family does [82, 85].
Pay attention to the needs of those close to the per-
son during the ACP process [9, 25, 63, 65, 86]. Suffi-
cient support, education and information are important,
as is addressing the concerns, experiences, expectations
and fears of the family. Family can be unprepared or feel
guilty [87]. Pay attention to the emotional process of
family members and consider that family dynamics
might change over time. It is not always easy to harmon-
ise the views of those close to the person with dementia.
ACP when it is difficult or no longer possible to
communicate verbally
In moderate/severe dementia, where verbal communication
is difficult or no longer possible, formulating care goals or
specific care preferences is difficult. Keep a connection
with the person with dementia and ensure their max-
imum participation [1, 42]. Respond to their emotions,
attend to non-verbal communication and observe be-
haviour to understand more about their current quality
of life, fears and desires [63]. People’s emotions can give
direction to the decision-making process [42]. Subse-
quently, actively involve family or other close people in
the ACP process and the expression of care goals and
wishes concerning end-of-life decisions [9, 25, 83] to get
an understanding of the life story of the person with de-
mentia and to interpret certain aspects of their behaviour
or emotions.
Documentation of wishes and preferences, including
information transfer
After every planned or unplanned ACP discussion, health-
care professionals should write down the outcome in the
patient’s medical/care files, e.g. the values, wishes or
care goals of the person and, where relevant, details of
an advance directive or legal representative [25, 88, 89].
If the person wishes, support them in formulating specific
wishes and advance decisions concerning the end of their
life, explore whether they have made a formal written ad-
vance directive in the past or if they want to make one
now [45] and provide information about the advantages
and disadvantages of advance directives [2, 71]. It is rec-
ommended that ACP documentation is evaluated regu-
larly as part of the ACP process, for example in
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anticipation of a ‘response shift’ [15, 25, 40, 47, 70]. Deci-
sions can be revised at all times.
The outcomes of the ACP process should be com-
municated within the care team, i.e. values, prefer-
ences and care goals and any advance directives or legal
representatives, particularly upon transfer to another
care setting. This can be done verbally or in writing.
Make sure relevant information is available to other care
providers in the shared sections of the care file or is eas-
ily accessible when needed, especially upon transfer to
another care setting. Information sharing should always
take professional confidentiality into account [66].
End-of-life decision-making
Despite all good intentions, ACP cannot anticipate all
possible scenarios. The disease trajectory is not always
predictable and the emotional burden on those close to
the person with dementia can often lead to a certain
amount of confusion and lack of clarity about providing
care. When end-of-life decisions need to be made, it is
important to weigh carefully the wishes expressed
and/or written down earlier against the current best
interest of the person living with dementia, in con-
sultation with the person’s close circle and the
healthcare professionals involved [84, 90, 91]. End-of-
life decision-making entails shared decision-making and
as much consensus amongst healthcare providers and
those close to the person as possible [84, 90, 91]. Mate-
rials such as the Framework for Weighing Previously
Expressed Preferences v. Best Interest can support pro-
fessionals and family in making these decisions, by ask-
ing questions such as: ‘is the clinical situation an
emergency that allows no time for deliberation?’, ‘in view
of the person’s values and goals, how likely is it that the
benefits of the intervention outweigh the burdens?’, ‘to
what degree does the advance directive fit the situation
at hand?’, ‘how much leeway did the patient allow the
surrogate in overriding the advance directive?’ or ‘how
well does the surrogate represent the patient’s best inter-
ests?’ [87].
Preconditions for optimal implementation of ACP
The optimal implementation of ACP requires improved
public understanding of end-of-life care issues [92] and
patients who are more informed or educated about ACP
[92]. Additionally, the provision of sufficient training
opportunities for healthcare professionals to learn
how to conduct ACP conversations is important. Ad-
equate support in practice is essential in making
healthcare professionals confident about engaging in
ACP [9, 20, 25, 93, 94]. Training should at least entail
the basic principles of ACP, the legal, deontological and
ethical framework, the importance and effectiveness of
ACP, a discussion of the professionals’ own barriers to
ACP, general communication techniques and active lis-
tening skills, documentation of advance directives, com-
munication with other professionals and how to make
decisions at certain times [9, 20, 25, 93, 94]. Interactive
sessions with role-plays, regular come-back sessions and
a specific focus on attitudes towards talking about death
and dying are also important [5, 25, 62, 95, 96]. These
training programmes should be organised for GPs,
nurses and social care workers, as the skills they provide
often function as an important facilitator between phys-
ician and patient [92, 97].
Integrate ACP into the mission and policy of the
organization and embed ACP in the organizational
culture [62, 97–99]. ACP should be part of daily prac-
tice and this requires a supportive culture within the
community or facility and an open attitude to conversa-
tions about end-of-life care and dementia among health-
care professionals. Within the facility there should be a
clear statement of intent and a formal policy concerning
ACP and how to embed it in routine care [1, 62, 92, 97–99].
Discussion
There are few guidelines available for healthcare profes-
sionals concerning ACP in people living with dementia,
especially those with early onset dementia. And those
guidelines are often not developed using high-quality re-
search, mainly because such research is lacking. Difficul-
ties implementing ACP in this population and the
evaluation of “active ingredients” necessary to success-
fully change outcomes are not fully addressed in re-
search and high-quality evaluation research such as
randomised design studies are still rare [6, 8]. By main-
taining a systematic approach, we could define a unique
set of recommendations to provide ACP to people living
with dementia and those close to them. In doing, so we
integrated the available expertise in dementia care in a
wide range of settings in Flanders with the existing evi-
dence on ACP as reported in the scientific literature.
Compared with ACP in other diseases where lack of
mental capacity is a less pronounced problem, perform-
ing ACP in dementia entails several significant and spe-
cific attention points. The most important concerns the
involvement of those close to the person with dementia.
Family members, next-of-kin and other significant people
are an important point of contact in communication and
decision-making in end-of-life care for people with de-
mentia, as their mental capacity gradually declines and
verbal communication becomes more difficult or even im-
possible [1]. Involvement of these people from the initial
stages of the condition is of the utmost importance in pro-
viding end-of-life care that corresponds to the wishes and
preferences of the person with dementia.
A second element very specific to ACP in people with
dementia is the trajectory of the decrease in mental
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capacity [81]. The clinical question of the evaluation of
mental capacity as part of the ACP process was heavily
debated by the author group and within the expert panel
and proved to be something which is difficult to do in
practice. Because of these discussions, we concluded that
mental capacity should be considered as a continuum
that fluctuates over time and is task-specific. In addition,
we recommend that formal, in-depth, multidisciplinary
assessments of capacity should not always be performed
before or during ACP conversations. However, it is im-
portant that care professionals hold ACP conversations
at different points over a period of time, making use of
spontaneous remarks on ACP-related issues by patients
or those close to them, as well as having planned con-
versations. Such conversations will not always follow a
predefined or structured format and will vary in content,
length and depth depending on the physical, cognitive
and psychological state of the person. In some cases, e.g.
when high-stake decisions need to be made, formal
multidisciplinary assessment and referral will be neces-
sary. However, further research is needed to substantiate
this recommendation.
ACP is an important part of care, especially in older
people and those living with dementia. Older people
themselves indicate that they find ACP valuable [17, 63]
and there is an important body of literature suggesting that
it has a positive impact on outcomes, ranging from family
satisfaction with care to concordance between end-of-
life care and patient wishes, especially for older people
and those living in nursing homes [100, 101]. There is add-
itional evidence, albeit of variable quality, which shows
that ACP has the potential to reduce inappropriate hos-
pital admissions and healthcare costs in nursing homes
where end-of-life care spending is already high [39, 102].
Further high-quality research, however, would strengthen
the arguments for ACP becoming part of routine demen-
tia care and provide information on how it can be carried
out effectively and sustainably [103]. More specifically,
we found insufficient research to support recommen-
dations on issues such as a uniform definition of lack
of mental capacity, contraindications for initiating
ACP and what to do if a person living with dementia
does not want to involve those close to them.
To the best of our knowledge, this is the first practical
guideline developed to improve the performance of
healthcare professionals in providing ACP to people liv-
ing with dementia across settings. Until now, existing
guidelines from guideline development groups (GDGs)
such as the National Institute for Health and Clinical
Excellence have only highlighted a few recommendations
concerning advance care planning, and these are limited
to ‘discuss the use of advance directives and identify sur-
rogates’ and ‘discuss cardiopulmonary resuscitation in
advance and inform patients about poor outcomes in
advanced dementia’ [26, 104]. Nonetheless, evidence
shows that ACP may be more effective in meeting a pa-
tient’s preferences when it entails more than just written
documents and a conversation [39, 101]. Local initiatives
have tried to provide guidance in ACP specifically for
people living with dementia, but standardization and
consistency are lacking [105]. By consulting both experts
and end users with different professional backgrounds,
we have been able to include broad multidisciplinary
support at a regional level for these recommendations.
In addition, rather than just requiring the experts to
agree or disagree with predefined statements, they were
actively involved in specifying the statements so that
greater consensus could be achieved. We consider this
an important feature of our work.
However, readers must be aware of several limitations
of this study. The first limitation is the rather small
number of experts (n = 10) and end users (n = 51) who
replied to the survey, and the limited number of peer-
review groups (n = 2). In addition, the main source from
which the recommendations are derived is low-quality
systematic reviews, studies in which the quality of evi-
dence was not assessed formally, and from the opinions
of professionals or experts. We also wish to make clear
that professionals must be aware of the policies and le-
gislation that govern the jurisdiction in which they work
and that they must abide by existing policies and legisla-
tion when applying the recommendations. Additionally,
healthcare professionals should of course apply these
recommendations in their workplaces to serve as a general
guide, but follow them subject to their own judgment and
each individual case. The recommendations serve neither
as an action programme nor as a strict guideline but pro-
vide a list of attention points for healthcare professionals
involved in dementia care. We recommend that they
should additionally be trained to perform ACP, because
merely providing and disseminating a guideline like this
will not be enough to improve their practice [106]. The re-
sults of this study can serve as a tool to educate healthcare
professionals.
The final guideline requires further testing in clinical
practice. However, initial feedback from experienced
healthcare professionals and other experts has indicated
that it can be helpful in terms of initiation, organisation
and implementation of ACP and when holding discus-
sions on end-of-life care. Such guidelines are shown to
play an important role in enabling good care up to the
end of life which is provided according to high ethical
and quality standards [1].
Conclusion
Little high-quality evidence is available on ACP in de-
mentia care. By combining the available evidence with
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expert and user opinions, we have defined a unique set
of recommendations for ACP in people living with de-
mentia. These recommendations will be used for the de-
velopment of a Flemish guideline for ACP in people
living with dementia and can serve as a valuable tool to
educate healthcare professionals on how to perform
ACP across settings.
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